The FDA’s database for drug approvals includes an Abbreviated New Drug Application (ANDA) numbered ANDA083639 submitted by Roche. The application covers the brand name ENDEP, an oral tablet formulation of amitriptyline hydrochloride.
The ANDA lists five product variants, each with a distinct strength—10 mg, 25 mg, 50 mg, 75 mg, and 100 mg. All five tablets are designated as “Discontinued” in marketing status, indicating they are no longer marketed.
規制動向2026年8月25日•1分で読めます
FDA Lists ENDEP Amitriptyline Tablet Products (ANDA083639)
FDA’s ANDA083639 lists five ENDEP oral amitriptyline tablets (10‑100 mg) from Roche, all marked discontinued.
PharmaCountryチームがまとめました · 出典： FDA.gov
評価
(0)
(0)
(0)
(0)
(0)
評価を残す